Analysts at BofA/Merrill (BAC) downgraded Intercept Pharmaceuticals, Inc. (ICPT) from ‘Buy‘ to ‘Neutral‘ in a research report issued to clients on Tuesday.
Intercept’s trailing-12-month revenue is $1.74 million while its return on assets for the same period is (180.8%).
Shares of the $6.50 billion market cap company are up 12.03% year-over-year and up 101.27% year-to-date.
Intercept Pharmaceuticals Inc., currently with a median Wall Street price target of $430.00 and a high target of $515.00, dropped $43.86 to $270.26 in recent trading.
The chart below shows where the equity has traded over the past 52-weeks.
Radiant Logistics, Inc. (RLGT) was downgraded from ‘Buy‘ to ‘Neutral‘ and the price target was set at $5.50 at ROTH Capital.
Shares have traded today between $5.21 and $5.70 with the price of the stock fluctuating between $2.93 to $6.09 over the last 52 weeks.
Radiant Logistics Inc. shares are currently changing hands at 47.36x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 0.52. EPS for the same period registers at $0.11.
Shares of RLGT have lost $0.63 to $5.21 in mid-day trading on Tuesday, giving it a market cap of roughly $219 million. The stock traded as high as $6.09 in April 6, 2015.
Eleven Biotherapeutics, Inc. (EBIO) was reiterated a ‘Outperform’ by Leerink Partners analysts on Tuesday. The broker also cut its price target on the stock to $6 from $23.
EBIO was down $0.33 at $3.36 in mid-day trade, moving within a 52-week range of $2.89 to $14.07. The name, valued at $65.00 million, opened at $3.60.
Urban Outfitters Inc. (URBN) rating of ‘Equal Weight’ was reiterated today at Barclays with a price target decrease of $37 from $40.
URBN closed at $40.72 on Monday and is currently trading down $6.40.
In the past 52 weeks, shares of Philadelphia, Pennsylvania-based specialty retail company have traded between a low of $27.89 and a high of $47.25 and are now trading at $34.28. Shares are up 12.46% year-over-year and 15.91% year-to-date.